What amount sold does Anuncia Medical, Inc. report in Form D filings?

The latest linked filings report $17.7M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Anuncia Medical, Inc.'s most recent SEC filing?

Anuncia Medical, Inc.'s most recent Form D filing was on 2025-11-21.

How many investors does Anuncia Medical, Inc. have?

The most recent Form D filing lists 87 investor(s).

What type of securities does Anuncia Medical, Inc. offer?

Anuncia Medical, Inc.'s SEC Form D filings indicate equity offerings.

Anuncia Medical, Inc.

CIK: 0001889938·Biotechnology·Scottsdale, AZ·Corporation

Reported Sold

$17,744,814

Total Filings

Identified Offerings

Last Filed

Nov 21, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Nov 21, 2025Form D/A — Amendment

Reported sold: $13,908,008 · Target: $16,442,486

Rule 506(b)·87 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 18, 2024Form D/A — Amendment

Reported sold: $12,189,298 · Target: $13,422,486

Rule 506(b)·69 investors

Changed: Reported amount sold, Reported investors, Finders fees

Sep 12, 2024Form D — New notice

Reported sold: $10,751,861 · Target: $13,422,486

Rule 506(b)·66 investors

Apr 24, 2024Form D/A — Amendment

Reported sold: $3,409,306 · Target: $4,000,000

Rule 506(b)·28 investors

Changed: Reported amount sold, Offering target, Reported investors

Oct 19, 2023Form D/A — Amendment

Reported sold: $2,614,306 · Target: $3,500,000

Rule 506(b)·22 investors

Changed: Reported amount sold, Offering target, Reported investors

Mar 29, 2023Form D/A — Amendment

Reported sold: $1,825,607 · Target: $2,500,000

Rule 506(b)·14 investors

Changed: Reported amount sold, Offering target, Reported investors

Sep 8, 2022Form D — New notice

Reported sold: $998,607 · Target: $1,500,000

Rule 506(b)·8 investors

Dec 17, 2021Form D/A — Amendment

Reported sold: $427,500 · Target: $1,500,000

Rule 506(b)·7 investors

Changed: Reported amount sold, Offering target, Reported investors

Oct 25, 2021Form D — New notice

Reported sold: $127,500 · Target: $700,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

67%

Latest reported sold across 3 identified offerings

$17,744,814

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Elsa Abruzzo

Related Person

Appears on 9 filings

PJ Anand

Related Person

Appears on 9 filings

Richard Upton

Related Person

Appears on 9 filings

David Donabedian

Related Person

Appears on 9 filings

Edgar D Janotta

Related Person

Appears on 9 filings

Stephen Oesterle

Related Person

Appears on 9 filings

Stanton Rowe

Related Person

Appears on 9 filings

Ghassan Kassab

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 21, 2025	Amendment	$16,442,486	$13,908,008	87
Nov 18, 2024	Amendment	$13,422,486	$12,189,298	69
Sep 12, 2024	New	$13,422,486	$10,751,861	66
Apr 24, 2024	Amendment	$4,000,000	$3,409,306	28
Oct 19, 2023	Amendment	$3,500,000	$2,614,306	22
Mar 29, 2023	Amendment	$2,500,000	$1,825,607	14
Sep 8, 2022	New	$1,500,000	$998,607	8
Dec 17, 2021	Amendment	$1,500,000	$427,500	7
Oct 25, 2021	New	$700,000	$127,500	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Gut-Brain-Axis Therapeutics Inc.

Biotechnology

Offering target: $20,000,000

Filed Oct 26, 2026